APL 0.00% 14.0¢ associate global partners limited

market depth shift, page-4

  1. SRF
    1,046 Posts.
    To correct the misinformation by Rob regarding the Bayer agreement for development of the 2nd test kits and why it was terminated:

    - TDX agreed to develop a second test kit for Bayer in Dec 2008.

    - A few thousand prototypes were shipped to Bayer in Nov 2009 for site evaluation.

    - In July 2011, it is reported that the 2nd test kit failed in one of the criteria and the reagent needed to be fixed for further field testing.

    - In August 2011, Bayer decided not to pursue the revision of the 2nd test kit. ( the field testing period was almost 18 months)

    Since TDX had failed to meet Bayer's performance criteria/specification for the 2nd test kit, it is entirely in Bayer's right to terminate the development as this is taking almost 3 years with no result.

    I sincerely hope that there is a favourable termination clause that is not performance base and that TDX is not liable if their test kit cannot meet the requirements.

    DYOR





 
watchlist Created with Sketch. Add APL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.